63 related articles for article (PubMed ID: 15618960)
1. Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFNalpha.
Brender C; Lovato P; Sommer VH; Woetmann A; Mathiesen AM; Geisler C; Wasik M; Ødum N
Leukemia; 2005 Feb; 19(2):209-13. PubMed ID: 15618960
[TBL] [Abstract][Full Text] [Related]
2. Tissue levels of suppressor of cytokine signaling-3 (SOCS-3) in mycosis fungoides.
Nada HR; Rashed LA; Salman OO; Abdallah NMA; Abdelhady MM
Arch Dermatol Res; 2023 Mar; 315(2):165-171. PubMed ID: 35226171
[TBL] [Abstract][Full Text] [Related]
3. Safety and Danger Considerations of Novel Treatments for Atopic Dermatitis in Context of Primary Cutaneous Lymphomas.
Kołkowski K; Trzeciak M; Sokołowska-Wojdyło M
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948183
[TBL] [Abstract][Full Text] [Related]
4. Patterns of Gene Expression in Cutaneous T-Cell Lymphoma: Systematic Review of Transcriptomic Studies in Mycosis Fungoides.
Motamedi M; Xiao MZX; Iyer A; Gniadecki R
Cells; 2021 Jun; 10(6):. PubMed ID: 34204115
[TBL] [Abstract][Full Text] [Related]
5. JAK3 Is Expressed in the Nucleus of Malignant T Cells in Cutaneous T Cell Lymphoma (CTCL).
Vadivel CK; Gluud M; Torres-Rusillo S; Boding L; Willerslev-Olsen A; Buus TB; Nielsen TK; Persson JL; Bonefeld CM; Geisler C; Krejsgaard T; Fuglsang AT; Odum N; Woetmann A
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33466582
[TBL] [Abstract][Full Text] [Related]
6. STAT3 Dysregulation in Mature T and NK Cell Lymphomas.
Seffens A; Herrera A; Tegla C; Buus TB; Hymes KB; Ødum N; Geskin LJ; Koralov SB
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31684088
[No Abstract] [Full Text] [Related]
7. Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome.
Hu T; Buus TB; Krejsgaard T; Nansen A; Lundholt BK; Spee P; Fredholm S; Petersen DL; Blümel E; Gluud M; Monteiro MN; Willerslev-Olsen A; Andersen MH; Straten PT; Met Ö; Stolearenco V; Fogh H; Gniadecki R; Nastasi C; Litman T; Woetmann A; Gjerdrum LMR; Ødum N
Oncotarget; 2019 Aug; 10(47):4894-4906. PubMed ID: 31448055
[TBL] [Abstract][Full Text] [Related]
8. Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma.
Lindahl LM; Willerslev-Olsen A; Gjerdrum LMR; Nielsen PR; Blümel E; Rittig AH; Celis P; Herpers B; Becker JC; Stausbøl-Grøn B; Wasik MA; Gluud M; Fredholm S; Buus TB; Johansen C; Nastasi C; Peiffer L; Kubat L; Bzorek M; Eriksen JO; Krejsgaard T; Bonefeld CM; Geisler C; Mustelin T; Langhoff E; Givskov M; Woetmann A; Kilian M; Litman T; Iversen L; Odum N
Blood; 2019 Sep; 134(13):1072-1083. PubMed ID: 31331920
[TBL] [Abstract][Full Text] [Related]
9. Constitutive STAT3 phosphorylation and IL-6/IL-10 co-expression are associated with impaired T-cell function in tuberculosis patients.
Harling K; Adankwah E; Güler A; Afum-Adjei Awuah A; Adu-Amoah L; Mayatepek E; Owusu-Dabo E; Nausch N; Jacobsen M
Cell Mol Immunol; 2019 Mar; 16(3):275-287. PubMed ID: 30886421
[TBL] [Abstract][Full Text] [Related]
10. PEDF-derived peptide promotes tendon regeneration through its mitogenic effect on tendon stem/progenitor cells.
Ho TC; Tsai SH; Yeh SI; Chen SL; Tung KY; Chien HY; Lu YC; Huang CH; Tsao YP
Stem Cell Res Ther; 2019 Jan; 10(1):2. PubMed ID: 30606221
[TBL] [Abstract][Full Text] [Related]
11. Insights into gene expression profiles induced by Socs3 depletion in keratinocytes.
Bajpai A; Ishii T; Miyauchi K; Gupta V; Nishio-Masaike Y; Shimizu-Yoshida Y; Kubo M; Kitano H
Sci Rep; 2017 Nov; 7(1):15830. PubMed ID: 29158586
[TBL] [Abstract][Full Text] [Related]
12. ONC201 selectively induces apoptosis in cutaneous T-cell lymphoma cells via activating pro-apoptotic integrated stress response and inactivating JAK/STAT and NF-κB pathways.
Ni X; Zhang X; Hu CH; Langridge T; Tarapore RS; Allen JE; Oster W; Duvic M
Oncotarget; 2017 Sep; 8(37):61761-61776. PubMed ID: 28977902
[TBL] [Abstract][Full Text] [Related]
13.
Herbaux C; Bertrand E; Marot G; Roumier C; Poret N; Soenen V; Nibourel O; Roche-Lestienne C; Broucqsault N; Galiègue-Zouitina S; Boyle EM; Fouquet G; Renneville A; Tricot S; Morschhauser F; Preudhomme C; Quesnel B; Poulain S; Leleu X
Oncotarget; 2017 Aug; 8(34):57451-57459. PubMed ID: 28924457
[TBL] [Abstract][Full Text] [Related]
14. Malignant inflammation in cutaneous T-cell lymphoma-a hostile takeover.
Krejsgaard T; Lindahl LM; Mongan NP; Wasik MA; Litvinov IV; Iversen L; Langhoff E; Woetmann A; Odum N
Semin Immunopathol; 2017 Apr; 39(3):269-282. PubMed ID: 27717961
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis.
Huang L; Hu B; Ni J; Wu J; Jiang W; Chen C; Yang L; Zeng Y; Wan R; Hu G; Wang X
J Exp Clin Cancer Res; 2016 Feb; 35():27. PubMed ID: 26847351
[TBL] [Abstract][Full Text] [Related]
16. Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma.
Willerslev-Olsen A; Krejsgaard T; Lindahl LM; Litvinov IV; Fredholm S; Petersen DL; Nastasi C; Gniadecki R; Mongan NP; Sasseville D; Wasik MA; Bonefeld CM; Geisler C; Woetmann A; Iversen L; Kilian M; Koralov SB; Odum N
Blood; 2016 Mar; 127(10):1287-96. PubMed ID: 26738536
[TBL] [Abstract][Full Text] [Related]
17. Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma.
Sibbesen NA; Kopp KL; Litvinov IV; Jønson L; Willerslev-Olsen A; Fredholm S; Petersen DL; Nastasi C; Krejsgaard T; Lindahl LM; Gniadecki R; Mongan NP; Sasseville D; Wasik MA; Iversen L; Bonefeld CM; Geisler C; Woetmann A; Odum N
Oncotarget; 2015 Aug; 6(24):20555-69. PubMed ID: 26244872
[TBL] [Abstract][Full Text] [Related]
18. PEDF-derived peptide promotes skeletal muscle regeneration through its mitogenic effect on muscle progenitor cells.
Ho TC; Chiang YP; Chuang CK; Chen SL; Hsieh JW; Lan YW; Tsao YP
Am J Physiol Cell Physiol; 2015 Aug; 309(3):C159-68. PubMed ID: 26040897
[TBL] [Abstract][Full Text] [Related]
19. Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell lines.
Litvinov IV; Cordeiro B; Fredholm S; Ødum N; Zargham H; Huang Y; Zhou Y; Pehr K; Kupper TS; Woetmann A; Sasseville D
Cell Cycle; 2014; 13(18):2975-82. PubMed ID: 25486484
[TBL] [Abstract][Full Text] [Related]
20. Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression.
Netchiporouk E; Litvinov IV; Moreau L; Gilbert M; Sasseville D; Duvic M
Cell Cycle; 2014; 13(21):3331-5. PubMed ID: 25485578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
